Immunocore Holdings plc SEC filings IMCR

Immunocore Holdings plc has 279 filings in SEC EDGAR's recent list, going back to Apr 13, 2016. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
10-K Annual report Feb 25, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 4, 2025 Dec 31, 2024
10-K Annual report Feb 26, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 12, 2024 Dec 31, 2023
10-K Annual report Feb 28, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Mar 1, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 3, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 25, 2021 Dec 31, 2020

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IMCR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Oxfordshire, United Kingdom
SEC filer status
Large accelerated filer
SEC CIK
1671927
Former names
Immunocore Ltd (until Feb 1, 2021)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.